Sector dividends Resverlogix Corp.

Stocks

Market Closed - Toronto S.E. 14:59:49 2026-08-18 EDT			5-day change	1st Jan Change
0.1000 ^CAD	+5.26%		0.00%	-

08-14	Resverlogix Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
06-25	Resverlogix Corp. - Shareholder/Analyst Call

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Dividend Yield (Y)	Dividend Yield (Y+1)	P/E (Y)	Price to Book (Y)	EV / Sales (Y)	EV / EBITDA (Y)	EV / EBIT (Y)	Capi.($)
RESVERLOGIX CORP.	-	-	-	-	-	-	-	24.75M
WUXI APPTEC CO., LTD.	1.34%	1.5%	22.02x	5.16x	7.72x	15.73x	17.79x	73.45B
ARGENX SE	0.04%	0.08%	36.15x	7.14x	9.26x	28.49x	28.84x	62.99B
INSMED INCORPORATED	-.--%	-.--%	-81.2x	39.35x	15.18x	-77.46x	-90.46x	28.05B
WUXI BIOLOGICS (CAYMAN) INC.	-.--%	-.--%	32.25x	3.1x	6.34x	16.79x	20.2x	25.42B
BIONTECH SE	-.--%	-.--%	-14.35x	1.14x	5.17x	-6.66x	-5.19x	23.3B
GENMAB A/S	-.--%	-.--%	26.57x	3.17x	5.01x	16.8x	18.89x	19.45B
PHARMAESSENTIA CORPORATION	0.29%	0.17%	52.91x	13.55x	19.58x	39.65x	43.13x	18.16B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-.--%	-.--%	-7088.72x	16.64x	40.96x	-262.55x	-178.63x	16.53B
EXELIXIS, INC.	-.--%	-.--%	16.43x	5.06x	4.87x	11.36x	12.09x	13.16B
ARROWHEAD PHARMACEUTICALS, INC.	-.--%	-.--%	-24.78x	31.88x	25.04x	-27.89x	-25.02x	12.42B
MADRIGAL PHARMACEUTICALS, INC.	-.--%	-.--%	-83.04x	26.99x	7.59x	-62.89x	-61.56x	12.12B
AKESO, INC.	-.--%	0.03%	-1065.4x	7.64x	13.49x	111.83x	778.72x	10.69B
CYTOKINETICS, INCORPORATED	-.--%	-.--%	-12.41x	-79.77x	62.89x	-13.11x	-12.86x	10.58B
SUMMIT THERAPEUTICS INC.	-.--%	-.--%	-11.63x	37.42x	2418.42x	-12.39x	-10.63x	10.23B
SPYRE THERAPEUTICS, INC.	-.--%	-.--%	-37.59x	9.68x	-	-33.52x	-34.29x	9.51B
REMEGEN CO., LTD.	-.--%	-.--%	11.07x	5.58x	8.34x	13.48x	14.26x	9.1B
VAXCYTE, INC.	-.--%	-.--%	-7.14x	-	-	-7.39x	-6.83x	8.9B
Average	0.1%	0.1%	-484.05x	8.36x	176.66x	-14.69x	29.91x	20.23B
Weighted average by Cap.	0.29%	0.33%	-347.90x	8.94x	84.11x	-6.96x	16.75x